Milton Maxwell Logo
Login

Pelthos Therapeutics Inc.

32.50+0.05 (+0.15%)
Oct 29, 4:00:00 PM EDT · NYSE American · PTHS · USD

Upcoming Earnings

Report date
≈ -

Key Stats

Market Cap
99.71M
P/E (TTM)
-
Basic EPS (TTM)
-14.66
Dividend Yield
0%

Recent Filings

About

Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.

CEO
Mr. Francis Knuettel II, M.B.A.
IPO
2/16/2024
Website
https://pelthos.com
Employees
4
Sector
Healthcare
Industry
Biotechnology

Related Companies

DNTH
Dianthus Therapeutics, Inc.
33.82+0.15
OMER
Omeros Corporation
7.68-0.28
PTHL
Pheton Holdings Ltd
0.64+0.02
PTIX
Protagenic Therapeutics, Inc.
2.58-0.18
RLMD
Relmada Therapeutics, Inc.
2.45+0.00
TELO
Telomir Pharmaceuticals, Inc.
1.50-0.01
TENX
Tenax Therapeutics, Inc.
7.23+0.01
TTIPF
-
0.58+0.00
ZEOX
Zeo ScientifiX Inc.
2.18+0.21
ZNTL
Zentalis Pharmaceuticals, Inc.
1.53-0.18